AVANIR PHARMACEUTICALS, INC.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
| Revenue | $115.0M | $75.4M | $41.3M | $10.5M | — |
| Operating income | −$46.3M | −$71.4M | −$58.4M | −$60.6M | −$27.1M |
| Net income | −$50.4M | −$75.5M | −$59.7M | −$60.6M | −$26.7M |
| Total assets | $307.0M | $76.1M | $86.0M | $89.6M | $42.1M |
| Total liabilities | $33.6M | $57.6M | $49.2M | $18.3M | $14.1M |
| Equity | $273.4M | $18.5M | $36.8M | $71.3M | $28.0M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 193.8M | 152.1M | 136.8M | 127.0M | 96.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- −40.3%
- Net margin
- −43.8%
- Return on equity
- −18.4%
- Return on assets
- −16.4%
- Return on capital (ROCE)
- −16.9%
- Liabilities / assets
- 10.9%
- Debt / equity
- 0.12×
- Book value / share
- $1.41
- Revenue growth (YoY)
- 52.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- 7.42safe
- Accruals / assets
- −0.6%clean
- Beneish M-Score
- -1.84normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 9, 2007
- NT 10-Kmissed a reporting deadline ↗Dec 15, 2006
- NT 10-Qmissed a reporting deadline ↗Aug 9, 2005
- NT 10-Qmissed a reporting deadline ↗May 10, 2005
- NT 10-Kmissed a reporting deadline ↗Dec 28, 1999
- NT 10-Kmissed a reporting deadline ↗Dec 30, 1998
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJan 13, 2015
- Entered a material agreement · Director / officer change · Other material eventDec 2, 2014
- Other material eventNov 28, 2014
- Director / officer changeNov 12, 2014
- Other material eventNov 7, 2014
- Entered a material agreementSep 25, 2014
- Other material eventSep 15, 2014
- Results of operationsAug 5, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- ARSAUTO-GENERATED PAPER DOCUMENTApr 28, 2015
- SC 13G/AAVNRFeb 11, 2015
- SC 13G/AAVNR AS OF 01/31/2015Feb 10, 2015
- SC 13G/AAVNR AS OF 12/31/2014Feb 9, 2015
- SC 13G/AJan 26, 2015
- 15-12BJan 15, 2015
- EFFECTJan 14, 2015
- EFFECTJan 14, 2015
- POS AMJan 13, 2015
- POS AMJan 13, 2015
- S-8 POSJan 13, 2015
- S-8 POSJan 13, 2015
- S-8 POSJan 13, 2015
- S-8 POSJan 13, 2015
- S-8 POSJan 13, 2015
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.